Find clinical trial centers near you
Find clinical trial centers with the largest number of active clinical trials
NEWS
September 16, 2010
Harbor reports positive data from Phase II/III prostate cancer trial
Harbor BioSciences, a biopharmaceutical company, has announced new positive data from its ongoing Phase I/IIa clinical trial with Apoptone for castration resistant prostate cancer, or CRPC, also referred to as hormone resistant prostate cancer.
September 11, 2010
Abiraterone after Ketoconazole
In September 2010, the University of California (San Francisco) initiated a Phase 2 clinical trial of abiraterone for men with castrate resistant prostate cancer that have progressed after being treated with ketoconazole
September 10, 2010
Neoadjuvant Study of In-situ REIC/Dkk-3 in Prostate Cancer
This is a Phase 1 clinical trial of neoadjuvant (pre-prostatetcomy) gene therapy followed by prostatectomy for men with a high risk of cancer recurrence after radical prostatectomy
Study of Investigational Agent Abiraterone Acetate for Metastatic Advanced Prostate Cancer Unblinded After Meeting Pre-Determined Criteria
LOS ANGELES, Sept. 9 /PRNewswire/ -- Ortho Biotech Oncology Research & Development, a unit of Cougar Biotechnology, Inc., today announced that it has unblinded the Phase 3 study of abiraterone acetate plus prednisone for the treatment of patients with metastatic advanced prostate cancer (also referred to as castration-resistant prostate cancer) whose disease has progressed following treatment with one or two chemotherapy regimens at least one of which contained docetaxel.
September 9, 2010
Study of MLN8237 in Patients With Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel/Prednisone Regimen
This is a Phase 2 clinical trial of MLN8237, an experimental drug, used in combination with docetaxel as a treatment for metastatic, castration-resistant prostate cancer (CRPC)
September 8, 2010
EDAP Reports Publication of Long-Term Clinical Results for Largest Cohort of Ablatherm-HIFU Patients
September 7, 2010
Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in the Treatment of Patients With Castration-Resistant Prostate Cancer Resistant to Docetaxel
CytRx Initiates Phase 2 Clinical Trial with Bafetinib in Advanced Prostate Cancer
September 6, 2010
TroVax In Subjects With Hormone Refractory Prostate Cancer (HRPC)
September 5, 2010
Speakers to discuss prostate cancer (at the Barbara Ann Karmanos Cancer Center in Farmington Hills, Michigan)
Featured Cancer Center
